✦ LIBER ✦

Extensive ischemic liver necrosis complicating hereditary hemorrhagic telangiectasia: a rare indication for liver transplantation

✍ Scribed by I. Bueres Dominguez; L Annet; F Waignein; C Sempoux; A Geubel

Book ID: 111237383
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 858 KB
Volume: 25
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2005.01116.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatic involvement in hereditary hemorr

Hepatic involvement in hereditary hemorrhagic telangiectasia: An unusual indication for liver transplantation

✍ Christian Hillert; Dieter C. Broering; Matthias Gundlach; Wolfram T. Knoefel; Ja 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Bevacizumab reverses need for liver tran

Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia

✍ Andrew Mitchell; Leon A. Adams; Gerry MacQuillan; Jon Tibballs; Rohan vanden Dri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characterized by mucocutaneous and visceral telangiectasia. Hepatic involvement with vascular malformations may lead to portal hypertension, biliary ischemia, and high-output cardiac failure. Liver transplantation is indica

Reply: Bevacizumab reverses need for liv

Reply: Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia

✍ Leon A. Adams; Andrew Mitchell; Gerry MacQuillan; Jonathon Tibballs; Rohan vande 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

unclear, and further experience in a clinical trial setting is required to clarify this. Lastly, it is exciting to ponder that vascular endothelial growth factor antagonists may have a role in reducing symptoms in the substantial number of HHT patients who are symptomatic but do not require liver tr

Liver transplantation as definitive ther

Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia

✍ Odorico, Jon S. ;Hakim, M. Nawar ;Becker, Yolanda T. ;Van der Werf, Willem ;Musa 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 536 KB

Experience with hepatic artery embolization for the treatment of symptomatic hepatic arteriovenous malformations (AVMs) in Rendu-Osler-Weber disease is limited. We report 2 cases of hepatic AVMs that caused mesenteric angina-like symptoms that were treated with embolization. Both patients developed